help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2004-0667
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
146/1/375    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gremlich, S.
Right arrow Articles by Wahli, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gremlich, S.
Right arrow Articles by Wahli, W.
Endocrinology Vol. 146, No. 1 375-382
Copyright © 2005 by The Endocrine Society

Pancreatic Islet Adaptation to Fasting Is Dependent on Peroxisome Proliferator-Activated Receptor {alpha} Transcriptional Up-Regulation of Fatty Acid Oxidation

Sandrine Gremlich1, Christopher Nolan1, Raphaël Roduit1, Rémy Burcelin, Marie-Line Peyot, Viviane Delghingaro-Augusto, Béatrice Desvergne, Liliane Michalik, Marc Prentki and Walter Wahli

Center for Integrative Genomics (S.G., B.D., L.M., W.W.), University of Lausanne, CH-1015 Lausanne, Switzerland; the Molecular Nutrition Unit and the Montreal Diabetes Research Center (C.N., R.R., M.-L.P., V.D.-A., M.P.), University of Montreal, Montreal, Quebec, Canada H2L 4M1; Hopital Rangueil (R.B.), 31403 Toulouse, France; and the Division of Medical Genetics (R.R.), Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland

Address all correspondence and requests for reprints to: Dr. Marc Prentki, Centre de Recherche, Centre Hospitalier de l’Université de Montréal, Pavillon de Sève, Y4603, 1560 Sherbrooke East, Montreal, Quebec, Canada H2L 4M1. E-mail: marc.prentki{at}umontreal.ca.

The cellular response to fasting and starvation in tissues such as heart, skeletal muscle, and liver requires peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha})-dependent up-regulation of energy metabolism toward fatty acid oxidation (FAO). PPAR{alpha} null (PPAR{alpha}KO) mice develop hyperinsulinemic hypoglycemia in the fasting state, and we previously showed that PPAR{alpha} expression is increased in islets at low glucose. On this basis, we hypothesized that enhanced PPAR{alpha} expression and FAO, via depletion of lipid-signaling molecule(s) for insulin exocytosis, are also involved in the normal adaptive response of the islet to fasting. Fasted PPAR{alpha}KO mice compared with wild-type mice had supranormal ip glucose tolerance due to increased plasma insulin levels. Isolated islets from the PPAR{alpha} null mice had a 44% reduction in FAO, normal glucose use and oxidation, and enhanced glucose-induced insulin secretion. In normal rats, fasting for 24 h increased islet PPAR{alpha}, carnitine palmitoyltransferase 1, and uncoupling protein-2 mRNA expression by 60%, 62%, and 82%, respectively. The data are consistent with the view that PPAR{alpha}, via transcriptionally up-regulating islet FAO, can reduce insulin secretion, and that this mechanism is involved in the normal physiological response of the pancreatic islet to fasting such that hypoglycemia is avoided.




This article has been cited by other articles:


Home page
DiabetesHome page
M. Kebede, J. Favaloro, J. E. Gunton, D. R. Laybutt, M. Shaw, N. Wong, B. C. Fam, K. Aston-Mourney, C. Rantzau, A. Zulli, et al.
Fructose-1,6-Bisphosphatase Overexpression in Pancreatic {beta}-Cells Results in Reduced Insulin Secretion: A New Mechanism for Fat-Induced Impairment of {beta}-Cell Function
Diabetes, July 1, 2008; 57(7): 1887 - 1895.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. R. Kapoor, J. Locke, K. Colclough, J. Wales, J. J. Conn, A. T. Hattersley, S. Ellard, and K. Hussain
Persistent Hyperinsulinemic Hypoglycemia and Maturity-Onset Diabetes of the Young Due to Heterozygous HNF4A Mutations
Diabetes, June 1, 2008; 57(6): 1659 - 1663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. A. Martens, A. Vervoort, M. Van de Casteele, G. Stange, K. Hellemans, H. V. Van Thi, F. Schuit, and D. Pipeleers
Specificity in Beta Cell Expression of L-3-Hydroxyacyl-CoA Dehydrogenase, Short Chain, and Potential Role in Down-regulating Insulin Release
J. Biol. Chem., July 20, 2007; 282(29): 21134 - 21144.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden
Peroxisome Proliferator-Activated Receptor-{alpha} and Glucocorticoids Interactively Regulate Insulin Secretion During Pregnancy
Diabetes, December 1, 2006; 55(12): 3501 - 3508.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. J. Nolan, M. S.R. Madiraju, V. Delghingaro-Augusto, M.-L. Peyot, and M. Prentki
Fatty Acid Signaling in the {beta}-Cell and Insulin Secretion
Diabetes, December 1, 2006; 55(Supplement_2): S16 - S23.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Knauf, J. Rieusset, M. Foretz, P. D. Cani, M. Uldry, M. Hosokawa, E. Martinez, M. Bringart, A. Waget, S. Kersten, et al.
Peroxisome Proliferator-Activated Receptor-{alpha}-Null Mice Have Increased White Adipose Tissue Glucose Utilization, GLUT4, and Fat Mass: Role in Liver and Brain
Endocrinology, September 1, 2006; 147(9): 4067 - 4078.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Lalloyer, B. Vandewalle, F. Percevault, G. Torpier, J. Kerr-Conte, M. Oosterveer, R. Paumelle, J.-C. Fruchart, F. Kuipers, F. Pattou, et al.
Peroxisome Proliferator-Activated Receptor {alpha} Improves Pancreatic Adaptation to Insulin Resistance in Obese Mice and Reduces Lipotoxicity in Human Islets
Diabetes, June 1, 2006; 55(6): 1605 - 1613.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. C. Corton and H. M. Brown-Borg
Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1494 - 1509.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Terauchi and T. Kadowaki
Peroxisome Proliferator-Activated Receptors and Insulin Secretion
Endocrinology, August 1, 2005; 146(8): 3263 - 3265.
[Full Text] [PDF]


Home page
EndocrinologyHome page
K. Ravnskjaer, M. Boergesen, B. Rubi, J. K. Larsen, T. Nielsen, J. Fridriksson, P. Maechler, and S. Mandrup
Peroxisome Proliferator-Activated Receptor {alpha} (PPAR{alpha}) Potentiates, whereas PPAR{gamma} Attenuates, Glucose-Stimulated Insulin Secretion in Pancreatic {beta}-Cells
Endocrinology, August 1, 2005; 146(8): 3266 - 3276.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society